Type
- Cancellation by sponsor (153)
- ARTG (98)
- Cancellation or suspension (4)
- Prescription medicine registration (4)
- Designation or determination (3)
- Face mask cancellation (3)
- Australian public assessment report (AusPar) (2)
- Prescription medicine decision summary (2)
- Face mask non-compliance notice (1)
- Prescription medicine evaluation (1)
Sponsor content
271 result(s) found, displaying 211 to 220
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Prescription medicine decision summaryTGA decision: Tukysa (tucatinib), in combination with trastuzumab and capecitabine, is approved to treat HER2-positive breast cancer.
-
-
AA-Med Pty Ltd - ReCell Autologous Cell Harvesting Device Cancelled under Section 41GL(d) of the Act
Cancellation by sponsorRequested by AA-Med Pty Ltd -
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - AtriCure® Isolator Synergy™ Access™ Clamp - Epicardial radio-frequency ablation probe; open-surgery.
-
Cancellation by sponsorRequested by AA-Med Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - General/multiple surgical laser system beam guide, single-use.